Irina Vlasova-St. Louis

Biomedical Research, United States of America

Accomplished biomedical specialist with expertise in molecular pathology and clinical genomics. Secured more than 2M USD in NIH research grant funding during her tenure at the University of Minnesota. Made numerous biomedical discoveries studying normal and pathological conditions at the molecular, cellular, and organismal levels, by integrating state-of-the-art techniques such as next-generation sequencing. Significant record of publications in high-impact journals, books, editorial reviews, and keynote conference presentations.

Irina Vlasova-St. Louis

2books edited

5chapters authored

Latest work with IntechOpen by Irina Vlasova-St. Louis

RNA therapies evolved as economical and widely applicable individualized treatment solutions. Novel RNA-based therapeutic vaccines (e.g., against SARS-CoV-2 infection) have been proven to be safe and effective, and many of them are approved by the United States Food and Drug Administration (FDA). This book presents distinct classes of RNA therapeutics, ranging from single-stranded antisense oligonucleotides (ASOs) and subclasses of RNA interferences (miRNAs and other RNAi) to in vitro transcribed and in vivo translated mRNAs drugs and RNA vaccines. The book also discusses some of the challenges in RNA drug engineering, delivery, and specificity, as well as highlights the improvement of pharmacological effectiveness in a wide range of diseases.

Go to the book